3/31/2024 | 30049071 | HARMLESS MEDICINES FOR HUMAN CONSUMPTION-CAPTOPRIL TABLET 25MG | SAVORITE PHARMACEUTICALS PRIVATE LIMITED | 600 | NOS | 4088.06 | GUINEA | JNPT/ NHAVA SHEVA SEA |
3/28/2024 | 30049069 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS: EMIN 25 MG TAB(PROMETHAZINE 25 MG ),PACK-48 X 50 X 10TAB | N CHIMANLAL ENTERPRISES | 48 | NOS | 208.16 | Guinea-Bissau | SAHAR AIR |
3/28/2024 | 30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS: AZITHRO-O MAX 200 MG SUSPENSION(AZITHROMYCIN 200MG/ 5 ML | N CHIMANLAL ENTERPRISES | 500 | NOS | 252.89 | Guinea-Bissau | SAHAR AIR |
3/28/2024 | 30042019 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS: SYSTANE ULTRA EYE DROPS(POLYETHYLENE GLYCOL (0.4% W/V) + | N CHIMANLAL ENTERPRISES | 50 | NOS | 278.18 | Guinea-Bissau | SAHAR AIR |
3/28/2024 | 30049029 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS: CLOZOLE -V6 TAB(CLOTRIMAZOLE VAGINAL OVULES 100 MG),PACK- | N CHIMANLAL ENTERPRISES | 200 | NOS | 64.57 | Guinea-Bissau | SAHAR AIR |
3/28/2024 | 30049048 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS: MAMOFEN 20MG TAB(TAMOXIFEN 20 MG ),PACK-300 X 10TAB | N CHIMANLAL ENTERPRISES | 300 | NOS | 74.25 | Guinea-Bissau | SAHAR AIR |
3/28/2024 | 30045090 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS: MULTI-9 TAB(MULTIVITAMINS TABS),PACK-150 X 10 X 10TAB | N CHIMANLAL ENTERPRISES | 150 | NOS | 140.43 | Guinea-Bissau | SAHAR AIR |
3/28/2024 | 30049072 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS: NIFISTAR RETARD30 MG TAB( NIFEDIPINE SR 30 MG),PACK-40 | N CHIMANLAL ENTERPRISES | 40 | NOS | 419.69 | Guinea-Bissau | SAHAR AIR |
3/28/2024 | 30049069 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS: DOLIPRANE 500 MGTAB (PARACETAMOL 500 MG ),PACK-90 X 50X1 | N CHIMANLAL ENTERPRISES | 90 | NOS | 455.2 | Guinea-Bissau | SAHAR AIR |
3/28/2024 | 30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS: LEEONE 1 GM INJ(CEFTRIAXONE INJN 1 GM WITHOUT WATER FOR I | N CHIMANLAL ENTERPRISES | 240 | VLS | 1668.41 | Guinea-Bissau | SAHAR AIR |